Raymond James & Associates Icad Inc Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$1.8 - $3.61 $352 - $707	-196 Reduced 1.0%	19,350 $40,000
Q1 2023 Apr 14, 2023	BUY	$1.2 - $2.84 $1,200 - $2,840	1,000 Added 5.39%	19,546 $24,000
Q4 2022 Feb 08, 2023	SELL	$1.6 - $2.37 $3,366 - $4,986	-2,104 Reduced 10.19%	18,546 $33,000
Q2 2022 Aug 12, 2022	SELL	$3.02 - $4.56 $3,322 - $5,016	-1,100 Reduced 5.06%	20,650 $83,000
Q1 2022 May 11, 2022	BUY	$3.92 - $7.48 $32,657 - $62,315	8,331 Added 62.08%	21,750 $97,000
Q4 2021 Feb 08, 2022	SELL	$6.7 - $11.38 $8,710 - $14,794	-1,300 Reduced 8.83%	13,419 $97,000
Q3 2021 Nov 02, 2021	BUY	$10.11 - $17.56 $148,809 - $258,465	14,719 New	14,719 $158,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $49.9M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.